Activation of Nrf2 successfully alleviated diastolic dysfunction and reduced NO in vivo (Yoon et al., 2021) and induced a significant increase in NQO1 expression, conferring beneficial antioxidant effects and reducing afterload in the myocardium of patients with HF (A. Zhang et al., 2018). The gene discussed is NFE2L2; the disease is hydrops fetalis.